RALEIGH, NC--(Marketwire - December 14, 2010) -
| Highlighted Links |
|
|
INC Research, LLC., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, today announced it has recently moved its headquarters into new offices at 3201 Beechleaf Court in Raleigh, which is in the Highwoods Tower II building. The additional space in the new facility more easily accommodates current company operations and anticipated business growth.
The company signed a multi-year deal to occupy nearly 120,000 square feet between the new location and its existing office it occupies at 4800 Falls of Neuse Road. INC Research’s Corporate Learning Center will be housed in the new space, which is dedicated to internal training and certification programs in project management and therapeutic clinical research, as well as its Project Solutions Lab where simulation training for staff at all levels and functions take place.
“This is an exciting stage in the history of INC Research,” said James Ogle, CEO of INC Research. “We have continued to enhance and expand our global drug development capabilities based on customer demand. This move better positions us to accommodate future growth of our clinical trials outsourcing services.”
INC Research has become a top 10 CRO in terms of volume and quality results for Phase I through Phase IV clinical trials. This past year, the company launched its Alliance Partnership division dedicated to the creation and management of strategic clinical delivery alliances with pharmaceutical and biotechnology customers. Its global office locations have expanded in emerging regions such as India, Latin America and Asia. The company’s Trusted Process methodology for managing clinical trials has highlighted the advantages of performance-based metrics to run trials more efficiently. INC Research is one of the top fastest growing private companies in the Research Triangle Park area as rated every year since 2004 by the Triangle Business Journal.
About INC Research, LLC.
INC Research is a therapeutically focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women’s health trials. The company’s Trusted Process® methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information please visit www.incresearch.com or follow us at @inc_research
Media contact:
Kelly Foster
Email Contact
+ 1 619-224-1261
Digg this
Bookmark with del.icio.us
Add to Newsvine
Technorati: 
